Igor F. Palacios

Showing 1-9 of 9 articles

How should I treat a coronary artery to pulmonary artery fistula at an acute stent thrombosis site?

Kannan A, Lee Z, Saleh L, Kanakadandi U, Rigatelli G, Lee S, Kasprzak J, Palacios I

December 20, 2017 | 10.4244/EIJ-D-16-00903

Coronary interventions

Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment

Pyxaras S, Hunziker L, Chieffo A, Meliga E, Latib A, Park S, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar R, Palacios I, Kim Y, Buszman P, Chakravarty T, Sheiban I, Mehran R, Margey R, Agnihotri A, Marra S, Capodanno D, Leon M, Moses J, Fajadet J, Lefèvre T, Morice M, Erglis A, Tamburino C, Alfieri O, Serruys P, Colombo A, Naber C

August 5, 2016 | 10.4244/EIJV12I5A102

Coronary artery bypass graft versus percutaneous coronary intervention with drug-eluting stent implantation for diabetic patients with unprotected left main coronary artery disease: the D-DELTA registry

Meliga E, De Benedictis M, Chieffo A, Latib A, Park S, Kim Y, Onuma Y, Capranzano P, Jegere S, Makkar R, Palacios I, Buszman P, Bande M, Chakravarty T, Mehran R, Naber C, Scrocca I, Margey R, Leon M, Moses J, Fajadet J, Lefèvre T, Morice M, Erglis A, Tamburino C, Alfieri O, Conte M, Serruys P, Colombo A

November 29, 2013 | 10.4244/EIJV9I7A133

Use of the Impella 2.5 system alone, after and in combination with an intra-aortic balloon pump in patients with cardiogenic shock: case description and review of the literature

Cubeddu R, Lago R, Horvath S, Vignola P, O’ Neill W, Palacios I

April 20, 2012 | 10.4244/EIJV7I12A226

Directional coronary atherectomy: a time for reflection. Should we let it go?

Cubeddu R, Truong Q, Rengifo-Moreno P, Garcia-Camarero T, Okada D, Kiernan T, Inglessis I, Palacios I

September 30, 2009

Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study Alfredo E.

Rodriguez A, Maree A, Tarragona S, Fernandez-Pereira C, Santaera O, Granillo R, Rodríguez-Granillo G, Russo-Felssen M, Kukreja N, Antoniucci D, Palacios I, Serruys P

June 30, 2009 | 10.4244/EIJV5I2A40

Diabetic patients treated for unprotected left main coronary artery disease with drug eluting stents: a 3-year clinical outcome study. The Diabetes and Drug Eluting stent for LeFT main registry (D-DELFT)

Meliga E, Garcia-Garcia H, Valgimigli M, Chieffo A, Biondi-Zoccai G, O’ Maree A, Gonzalo N, Cook S, Cruz-Gonzalez I, Marra S, De Servi S, Palacios I, Windecker S, van Domburg R, Colombo A, Sheiban I, Serruys P

May 13, 2008

Late stent thrombosis: the Damocles' sword of drug eluting stents?

Rodriguez A, Rodríguez-Granillo G, Palacios I

February 20, 2007

Revascularization strategies of coronary multiple vessel disease in the Drug Eluting Stent Era: one year follow-up results of the ERACI III Trial

Rodriguez A, O’ Maree A, Grinfeld L, Fernandez-Pereira C, Mieres J, Alemparte MR, Berrocal D, Rodríguez-Granillo G, Vigo C, Felsen M, O’ Neill W, Palacios I

May 20, 2006

1

Latest news

LM revascularisation, annulus rupture, risk stratification, renal denervation

EAPCI survey results: The impact of COVID-19

Marco Roffi, Dariusz Dudek, et al.

A perspective from EAPCI Women and Women as One

Gill Louise Buchanan

Last Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

EuroIntervention new Editorial Board

This week’s JAA’s: Paradigm Study: 12months outcome, GLASSY ACS vs SIHD...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke